Regulatory advancements in Japan's conditional and time-limited approval scheme for regenerative medical products: the first guidance on the approval scheme and the second review for full approval of the first conditional and time-limited approved cellular product, HeartSheet

Shinichi Noda, Y. Kobayashi, Narumi Okura, Kayo Shinohara, Junichi Asano, Jun Matsumoto